GENE ONLINE|News &
Opinion
Blog

RNA
Orna Therapeutics Secures Multi-Billion RNA Deal With Merck After $221 Million Series B
2022-08-17
Single Cell Sequencing – the Current Players
2022-08-04
Life Began with RNA Theory Gets Renewed Support
2022-05-20
RNA Therapeutics Beyond Vaccines
2022-05-19
JPM22 Highlights: Amgen Sees Potential in Arrakis, Freenome Gets Boosted by Roche Again
2022-01-12
RNAi Player Sirnaomics Squeezes in $50 Million IPO in Hong Kong
2022-01-03
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Scientists Engineer RNA Switches for Targeted Delivery of Gene Therapy and RNA Therapeutics
2021-11-07
Current Challenges and Future Opportunities of Artificial RNA Editing – An Interview with Professor Toshifumi Tsukahara
2021-08-26
Scientists Unveil Novel Protein That Delivers Molecular Medicines to Human Cells
2021-08-25
Laronde Launches to Disrupt the Industry with Programmable Circular RNA Therapies
2021-05-15
Orna Therapeutics Brings to Market New Therapy to Treat Cancer and Other Diseases
2021-02-26
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
Locanabio Raises $100M to Advance CRISPR-Mediated RNA-Targeting Therapies
2020-12-18
Proximity RNA Sequencing: Breaking New Grounds in Spatial Transcriptomics
2020-06-28
1 2
LATEST
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
Partnership to Manufacture Antibiotic to Combat Antimicrobial Resistance
2023-09-25
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Largest Biotech Event of Thailand Takes Center Stage
2023-09-22
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top